Biopol Chemicals
CLOSEDIPO Date: 6 Feb - 10 Feb 2026
Listing Date: 13 Feb 2026
Price Range
Rs.102 - Rs.108
Issue Size
31 Cr
Min Investment
₹1,22,400
Lot Size
1200 Shares
Schedule of Biopol Chemicals
Issue open date
6 Feb 2026
Issue close date
10 Feb 2026
UPI mandate deadline
10 Feb 2026 (5 PM)
Allotment finalization
11 Feb 2026
Share credit
12 Feb 2026
Listing date
13 Feb 2026
Mandate end date
25 Feb 2026
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 31 Cr |
| Fresh Issue | 31.26 Cr |
| Offer for Sale | 0 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 11 Feb 2026 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 12 Feb 2026 | ₹108 | ₹4 | ₹112 (3.7%) |
| 9 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 8 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 7 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 5 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 4 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 3 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 2 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 1 Feb 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 31 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 30 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 29 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 28 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 27 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 26 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 25 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
| 24 Jan 2026 | ₹108 | ₹0 | ₹108 (0%) |
Performance Biopol Chemicals
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| Rs.102 - Rs.108 | ₹ 222 (2.78%) | ₹ 106.4 | -1.48% |
About Biopol Chemicals
Biopol Chemicals is engaged in the trading, manufacturing, and distribution of speciality chemicals across the categories of silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s product portfolio comprises 66 products: 40 silicone-based, 5 emulsifier-based, 15 biochemical, and 6 polyelectrolyte. These products are used in applications such as softeners, emulsions, and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants for agriculture; and release agents for industrial chemicals. Biopol Chemicals also provides technical consultancy services related to the application of speciality chemicals in textile processing, dye manufacturing, and industrial formulations. The company operates on a business-to-business (B2B) model and serves institutional clients through direct sales and a distributor network in domestic and international markets. As of December 31, 2025, the company had four establishments in Gujarat and West Bengal, including a manufacturing unit, corporate office, and warehouse in West Bengal, and a registered office in Gujarat.
| Founded in | 2023 |
| Managing director | Mr Santanu Sarkar |
| Parent organization |
Financial Overview
Strengths
- Diversified speciality chemicals portfolio across silicones, biochemicals, emulsifiers, and polyelectrolytes.
- Strong presence in the textile chemicals segment with established institutional customers.
- Promoter-led company with domain experience and operational continuity from legacy business.
- B2B business model with repeat demand and technical consultancy support.
- Consistent revenue growth and profitability over recent financial periods.
Risks
- High dependence on the textile industry exposes revenue to sector cyclicality.
- Geographic concentration of revenue in West Bengal, Gujarat, and Bangladesh.
- Dependence on a limited number of raw material suppliers.
- First public issue with no prior listed market history for equity shares.
- Regulatory and environmental compliance risks inherent to chemical manufacturing.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 21.05 |
| Non-Institutional Investors (NIIs) | 21.55 |
| Retail Individual Investors (RIIs) | 19.88 |
| Employee | N/A |
| Total | 20.87 |